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Abstract – 1-t-Butyl- and 1-(4-methylbenzyl)-3-bromo-3-methylazetidines were prepared from the 
corresponding N-(2,3-dibromo-2-methylpropylidene)alkylamines and their propensity to undergo 
nucleophilic substitution at the 3-position by different nucleophiles was assessed, providing a 
convenient access to novel 3-alkoxy-, 3-aryloxy-, 3-hydroxy-, 3-cyano-, 3-carboxy-, 3-
(aminomethyl)- and 3-(hydroxymethyl)azetidines.   
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Within azaheterocyclic chemistry, azetidines represent a valuable class of strained nitrogen-
containing compounds from both a biological
1
 and a synthetic point of view.
2 In particular, 3-
substituted azetidines have attracted considerable interest because of the diverse biological 
activities associated to this type of compounds. For example, 3-alkoxy- and 3-
aryloxyazetidines have been described as G-protein coupled receptor agonists,
3
 inhibitors of 
stearoyl-coenzyme d-9 desaturase,
4
 and antibacterial agents.
5
 Moreover, 3-haloazetidines 
(without an additional alkyl group at the 3-position) are generally recognized as good 
substrates in organic chemistry for the preparation of other 3-functionalized azetidines.
6
  
Recently, the convenient synthesis of 3-methoxy-3-methylazetidines 3 through ring 
rearrangement of 2-bromomethyl-2-methylaziridines 2, obtained by NaBH4-mediated 
reduction of the corresponding α,β-dibromo imines 1, upon treatment with NaBH4 in 
methanol under reflux has been described by us.
7
 The same azetidines 3 have also been 
prepared via a different route through NaBH4-mediated cyclization of N-alkylidene-(3-
bromo-2-methoxy-2-methylpropyl)amines.
8
 In general, halogenated imines comprise useful 
intermediates for the preparation of azaheterocyclic compounds such as aziridines and 
azetidines.
9
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Furthermore, if aziridines 2 were heated in acetonitrile under reflux, 3-bromoazetidines 4 
were obtained as the thermodynamic products (Scheme 1).
7
 Until then, the peculiar 
rearrangement of 2-(halomethyl)aziridines to 3-haloazetidines had been observed in the 
literature in only two specific cases.
10
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Scheme 1. Reactivity of 2-bromomethyl-2-methylaziridines 2. 
 
In general, the reactivity profile of 3-bromo-3-methylazetidines as useful synthons in organic 
chemistry has not been studied so far. In this Letter, the synthesis of 3-bromo-3-methyl-1-(4-
methylbenzyl)azetidine and 3-bromo-1-t-butyl-3-methylazetidine will be covered, as well as 
their propensity to undergo nucleophilic substitution at the 3-position to access a window of 
novel 3-functionalized azetidines.  
The synthesis of 3-bromo-3-methyl-1-(4-methylbenzyl)azetidine 9 was performed via 
thermal ring expansion of 2-bromomethyl-2-methylaziridine 8 upon heating in acetonitrile 
under reflux according to a literature protocol (Scheme 2).
7
 Aziridine 8 was prepared by 
reductive cyclization of α,β-dibromoaldimine 7a (R = 4-MeC6H4CH2), obtained via 
bromination of 2-methylpropenal 5 and subsequent condensation with 4-methylbenzylamine 
in the presence of titanium(IV) chloride and triethylamine.
7
 In the same work, it has been 
shown that 3-methoxy-3-methylazetidines 3 were obtained upon treatment of imines 7 (R = 
CH2Ar) with sodium borohydride in methanol under reflux. Considering this smooth imine 7 
(R = CH2Ar) to azetidine 3 transformation, different reaction conditions were evaluated to 
obtain 3-bromoazetidine 9 directly from imine 7a. The reaction of imine 7a with 1 molar 
equiv of LiAlH4 in diethyl ether for 18 hours under reflux resulted only in aziridine 8, while 
the same reaction in tetrahydrofuran for a prolonged reaction time (5 days) gave a mixture of 
ring-opened amines derived from the hydride-induced ring opening of aziridine 8.
11
 The 
reduction of imine 7a, either with 1 molar equiv of LiAlH4 in dioxane for 15 hours under 
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reflux or with 2 molar equiv of NaBH4 in isopropanol for 15-24 hours under reflux, gave 
complex reaction mixtures, in which no 3-bromoazetidine 9 could be detected. Therefore, the 
most efficient synthesis of azetidine 9 was shown to occur via thermal rearrangement of 
aziridine 8.  
Contrary to the reactivity of N-(arylmethyl)imine 7a, treatment of N-t-butylimine 7b with 2.5 
molar equiv of NaBH4 in methanol for 4 hours at room temperature selectively provided 
amine 10 instead of 2-bromomethyl-1-t-butyl-2-methylaziridine (Scheme 2). These 
observations are in accordance with the NaBH4-mediated reduction of chlorinated imines 
towards the synthesis of different 1-alkyl-2-chloromethyl-2-methylaziridines, except in the 
case of the 1-t-butyl derivative where the formation of the corresponding aziridine was also 
never observed.
12
 When amine 10 was further heated in methanol or ethanol for 12 hours 
under reflux, a mixture of azetidines 11 and 12a,b (as their hydrobromic salt) was obtained. It 
should be noted that even if the corresponding 2-bromomethyl-2-methylaziridine was formed 
in this step, it immediately rearranged into azetidines 11 and 12 as the thermodynamically 
preferred products. Heating of amine 10 in a less nucleophilic solvent such as isopropanol for 
16 hours under reflux provided only 3-bromoazetidine hydrobromide 11, which was then 
isolated as a neutral compound upon treatment with a sodium hydroxide solution in 83% 
yield. In addition, treatment of imine 7b with 1 molar equiv of LiAlH4 in diethyl ether for 18 
hours under reflux gave 3-bromoazetidine 11 as the major product (75%), together with some 
non-identified side products (Scheme 2). Again, no traces of 2-bromomethyl-1-t-butyl-2-
methylaziridine were observed.  
4 
 
N
Br
Br
Br
H
N
Br
Br
H
O
H
O
R2.5 equiv 
NaBH4
NaBH4
MeOH, r.t., 36 h
LiAlH4 
Et2O, , 18 h
or
N
Br
1 equiv LiAlH4 
Et2O, , 18 h
75%
MeOH or EtOH
, 12 h
+
N
OR1
N
Br
Br
Br
N
H
5 6 (98%)
7a (R = 4-MeC6H4CH2, 64%)
7b (R = tBu, 69%)
8 (82-85%) 9 (62%)
10 (93%)
(R1 = Me)  11/12a = 84 : 16
(R1 = Et)   11/12b = 80 : 20
(R1 = iPr)  11/12c = 100 : 0
1.05 equiv Br2
CH2Cl2, r.t., 2.5 h
0.6 equiv TiCl4
3 equiv Et3N
Et2O, 0°C      r.t., 4 h
1 equiv
4-MeC6H4CH2NH2 
or tBuNH2
15 h,
CH3CN
MeOH, r.t., 4 h
 iPrOH, , 16 h
or
11 12
83%
 
Scheme 2. Synthesis of 3-bromo-3-methylazetidines 9 and 11. 
 
The formation of 3-alkoxyazetidines 12a,b from amine 10 is proposed to occur via 
nucleophilic attack of the solvent molecule (methanol or ethanol) at the more-substituted 
carbon atom of the intermediate bicyclic aziridinium ion 13 (Scheme 3). This strained 
intermediate 13 is most probably formed via intramolecular nucleophilic displacement of 
bromide in the initially formed 3-bromoazetidine 11. The proposed pathway concurs with the 
previously reported synthesis of 3-methoxy-3-methylazetidines 3 (R
1
 = CH2Ar, R
2
 = Me, 
Scheme 3) comprising the smooth ring expansion of 2-bromomethyl-2-methylaziridines 2 via 
bicyclic aziridinium intermediates 14 upon heating in methanol in the presence of NaBH4.
7 
In 
the same study, it has been shown that 3-methoxy-3-methylazetidines 3 can also be obtained 
starting from 3-bromoazetidines 4 applying the same reaction conditions (NaBH4, MeOH, Δ).  
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Scheme 3. Synthesis of 3-alkoxy-3-methylazetidines 12. 
 
The latter transformation served as a starting point to thoroughly investigate the synthetic 
potential of 3-bromo-3-methylazetidines for the preparation of novel 3-substituted azetidines. 
For this purpose, 3-bromo-3-methyl-1-(4-methylbenzyl)azetidine 9 and 3-bromo-1-t-butyl-3-
methylazetidine 11 were selected as eligible substrates for reactions with different 
nucleophiles.   
Upon heating of 3-bromo-1-t-butylazetidine 11 (R = tBu) in different alcohols (MeOH, 
EtOH, iPrOH) for 24-72 hours under reflux, the corresponding 3-alkoxyazetidines 12a-c 
were formed in pure form after basic work-up (Scheme 4). Furthermore, the reactions of 
azetidines 9 and 11 with 1-2.2 equiv of different phenols and 2-5 equiv of K2CO3 in 
tetrahydrofuran or acetonitrile for 4-48 hours under reflux provided the corresponding 3-
aryloxyazetidines 15a-d in good yields, which were purified by means of column 
chromatography on silica gel in order to obtain analytically pure samples.
13
 When substrates 
9 and 11 were heated in water or water/CH2Cl2 (9/1) for 10-24 hours under reflux in the 
presence of 5 equiv of KOH or 2 equiv of K2CO3, 1-t-butyl-3-methyl-3-azetidinol 16a and 3-
methyl-1-(4-methylbenzyl)-3-azetidinol 16b were obtained in high yields (Scheme 4).
14
 The 
above-described findings support the suitability of 3-bromo-3-methylazetidines as substrates 
for nucleophilic substitutions by different oxygen-centered nucleophiles.   
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Scheme 4. Reactivity of 3-bromo-3-methylazetidines 9 and 11 towards oxygen nucleophiles. 
 
In the literature, it is known that azetidine-3-carbonitriles can be prepared via nucleophilic 
substitution of 3-mesyloxy- and 3-tosyloxyazetidines.
15
 In that respect, 3-bromo-3-
methylazetidines 9 and 11 were also shown to be good substrates for the synthesis of 
azetidine-3-carbonitriles 17a,b upon treatment with 1.5 equiv of KCN in dimethylsulfoxide 
or acetonitrile for 13-22 hours under reflux (Scheme 5). Azetidine 17a was purified via 
distillation and azetidine 17b by means of column chromatography on silica gel, which were 
then used for further derivatization.  
The hydrolysis of the cyano group in azetidines 17 can provide an access towards cyclic 
amino acids which can be considered as analogues of azetidine-2-carboxylic acid, a natural 
molecule isolated from Convallaria majalis (lily-of-the-valley) and endowed with impressive 
biological activities such as the inhibition of the proliferation of Escherichia coli, alteration 
of the structure of collagen, keratin and haemoglobin in human proteins, and teratogenic 
effects and various malformations in animals.
1e
 Thus, the reaction of azetidine 17a with 5 
equiv of KOH in ethanol under reflux resulted in the corresponding new amino acid 1-t-
butyl-3-methylazetidine-3-carboxylic acid 18 (23% after purification on a Dowex column) 
after a prolonged reaction time (120 hours) and without traces of the corresponding amide. 
The carboxy group in azetidine 18 was then successfully reduced using 2 molar equiv of 
LiAlH4 in diethyl ether for 3 hours at room temperature to form 3-(hydroxymethyl)azetidine 
19 in 90% yield. Furthermore, 3-(aminomethyl)azetidine 20 was obtained after reduction of 
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the cyano group with 2 molar equiv of LiAlH4 in diethyl ether for 14 hours at room 
temperature.
16
 
A number of experiments were also performed concerning the hydrolysis of the cyano group 
in 1-(4-methylbenzyl)azetidine-3-carbonitrile 17b. The treatment of azetidine 17b with 5 
equiv of KOH in EtOH/H2O (5/1) under microwave irradiation (150 °C, 15 min, 150 W) and 
subsequent neutralization with a solution of hydrochloric acid (1M) gave the corresponding 
new amino acid 21. Interestingly, two isomeric structures (ratio 3/2) of azetidine 21 were 
observed upon NMR analysis (CD3OD), which can be attributed to the zwitterionic nature of 
this compound providing two diastereomeric counterparts. The purification of amino acid 21 
on Dowex H
+
 (NH4OH) afforded ammonium 3-methyl-1-(4-methylbenzyl)azetidine-3-
carboxylate 22 as a single isomer in pure form.
17
 These observations further support the 
synthetic utility of 3-bromo-3-methylazetidines as substrates for nucleophilic displacements, 
e.g. towards the synthesis of versatile 3-methylazetidine-3-carbonitriles.  
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Scheme 5. Synthesis and reactivity of 3-methylazetidine-3-carbonitriles 17a,b.  
 
In conclusion, efficient syntheses of 3-bromo-3-methylazetidines 9 and 11 were disclosed 
starting from 2-bromomethyl-2-methylaziridine 8 and β,γ-dibrominated amine 10, 
respectively. Through a number of examples, the azetidines 9 and 11 were shown to easily 
undergo nucleophilic substitution with different nucleophiles, providing a convenient method 
for the preparation of new synthetically and biologically attractive 3-substituted azetidines 23 
8 
 
such as 3-alkoxy-, 3-aryloxy-, 3-hydroxy-, 3-cyano-, 3-carboxy-, 3-(aminomethyl)- and 3-
(hydroxymethyl)azetidines  (Scheme 6).  
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Scheme 6. 3-Bromo-3-methylazetidines 9 and 11 as building blocks for the preparation of 3-
substituted 3-methylazetidines 23.  
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 Synthesis of ammonium 3-methyl-1-(4-methylbenzyl)azetidine-3-carboxylate 22. 1-(4-
Methylbenzyl)azetidine-3-carbonitrile 17b (0.20 g, 1 mmol) was dissolved in EtOH/H2O 
(5/1, 5 mL), after which KOH (0.28 g, 5 equiv) was added. The mixture was placed in an 6-
mL sealed glass vessel, provided with an appropriate stirring bar and subjected to microwave 
conditions (150 °C, 15 min, 150 W). The reaction mixture was neutralized with a solution of 
hydrochloric acid (1M) to pH = 7 and water was evaporated under high vacuum. Purification 
of amino acid 21 (two isomeric forms confirmed by NMR analysis) by means of ion-
exchange chromatography on Dowex H
+
 (50 x 8-100) afforded ammonium 3-methyl-1-(4-
methylbenzyl)azetidine-3-carboxylate 22 (0.20 g, 85%). White crystals; Mp > 350 °C. Yield 
85%; 
1
H NMR (300 MHz, CD3OD)  1.41 (3H, s), 2.24 (3H, s), 3.73 and 4.20 (4H, 2 x d, J = 
10.7 Hz), 4.20 (2H, s), 7.16-7.27 (4H, m). 
13
C NMR (75 MHz, CD3OD)  21.3, 23.3, 42.3, 
59.4, 63.7, 128.6, 131.0, 131.1, 141.2, 180.5. IR (neat, cm
-1
) CO = 1603. MS (70eV) m/z (%) 
218 (M
+ 
+ 1, 100).  
 
 
